74 products having the ‘Silent War’ in the shingles treatment market

A number of domestic pharmaceutical companies entered and competed in the shingles treatment ‘Famciclovir’ market.

Since Novartis Korea introduced the product in Korea in 2001, its 73 generic products have been approved, becoming the common product that every company must have.

As its patent is about to be expired on the coming 23^rd of November, particularly, the market seems to be revitalize...